首页 | 本学科首页   官方微博 | 高级检索  
检索        

血液病与骨髓微血管研究进展
引用本文:吴迪炯,周郁鸿,叶宝东,俞庆宏.血液病与骨髓微血管研究进展[J].中国实用内科杂志,2011(11):871-873.
作者姓名:吴迪炯  周郁鸿  叶宝东  俞庆宏
作者单位:浙江省中医院血液科;
基金项目:浙江省中医药重大疾病科技创新平台科研专项(2009ZDJB01); 中医药行业科研专项(NO.201107001)
摘    要:骨髓微血管在血液系统疾病的发生发展中具有重要作用,其形成受多种调控因子的交互影响。目前在多种恶性血液病及非恶性血液病均发现存在血管生成的异常,骨髓微血管密度可作为判断疾病预后的重要指标,并在部分疾病中具有分层意义。通过给予相应的治疗,抑制或促进血管新生对提高疾病疗效具有重要意义,但部分疗效机制仍有待于深入探讨。

关 键 词:骨髓微血管  血液病  调控因子

Advances in blood diseases and bone marrow microvessel
WU Di-jiong,ZHOU Yu-hong,YE Bao-dong,YU Qing-hong.Advances in blood diseases and bone marrow microvessel[J].Chinese Journal of Practical Internal Medicine,2011(11):871-873.
Authors:WU Di-jiong  ZHOU Yu-hong  YE Bao-dong  YU Qing-hong
Institution:WU Di-jiong,ZHOU Yu-hong,YE Bao-dong,YU Qing-hong.Zhejiang Hospital of Traditional Chinese Medicine,Hangzhou 310006,China
Abstract:Bone marrow microvessel plays an important role in the development and progression of hematologic diseases,and is regulated by a variety of regulatory factors.Since abnormal angiogenesis has been shown in a number of malignant and non-malignant hematologic diseases,microvessel density can be valuable as a prognostic indicator,and also as a stratifying factor in some of these diseases.In some cases,inhibiting or stimulating angiogenesis with certain treatment may seem important in improve the outcomes.Howeve...
Keywords:bone marrow microvessel  hematologic diseases  regulatory factor  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号